Literature DB >> 15690311

ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth.

Piers R Blackett1, Kathleen S Blevins, Elaine Quintana, Martha Stoddart, Wenyu Wang, Petar Alaupovic, Elisa T Lee.   

Abstract

Because Native Americans are predisposed to obesity and type 2 diabetes associated with coronary artery disease, we assessed whether apoC-III bound to apoB-containing (LpB:C-III) and apoA-containing (LpA:C-III) lipoproteins, total apoC-III, apoB, and plasma lipids are associated with insulin resistance, body mass index (BMI), and waist circumference in Cherokee children and adolescents aged 5 to 19 years (n = 975). A cross-sectional analysis was done to determine associations of the lipoproteins with the homeostasis index (HOMA-IR) and BMI. When the data were grouped by quartiles for HOMA-IR and separated by three 5-year age groups (5-9, 10-14, and 15-19 years), the trend for LpB:C-III, triglyceride, and BMI z score to increase was significant for all age groups and both genders (P < .001). The trend to increase LpB:C-III with age was greater in boys (P < .0001) than in girls (P < .05) who tended to plateau after the age of 10 years. In contrast, the ratio of LpA:C-III to LpB:C-III decreased and the decrease was greater in boys (P < .0001) than girls (P < .01). Body mass index z score and waist circumference were correlated with LpB:C-III, triglyceride, apoB, and non-high-density lipoprotein cholesterol within each gender (P < .001). In multiple regression models, LpB:C-III, the dependent variable, was associated with HOMA-IR for both genders. We conclude that increases in LpB:C-III in childhood and adolescence are associated with insulin resistance and obesity supporting the need for prevention programs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15690311     DOI: 10.1016/j.metabol.2004.08.010

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.

Authors:  Arman Qamar; Sumeet A Khetarpal; Amit V Khera; Atif Qasim; Daniel J Rader; Muredach P Reilly
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-11       Impact factor: 8.311

2.  Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.

Authors:  Arpita Basu; Ionut Bebu; Alicia J Jenkins; Julie A Stoner; Ying Zhang; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; Matthew J Budoff; Petar Alaupovic; Timothy J Lyons
Journal:  J Lipid Res       Date:  2019-06-15       Impact factor: 5.922

3.  Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort.

Authors:  Alicia J Jenkins; Jeremy Yu; Petar Alaupovic; Arpita Basu; Richard L Klein; Maria Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; Daniel T Lackland; W Timothy Garvey; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2013-07-11       Impact factor: 2.852

4.  Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.

Authors:  N Knowlton; J A Wages; M B Centola; J Giles; J Bathon; C Quiroga; P Alaupovic
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-07       Impact factor: 4.794

5.  Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.

Authors:  Wenyu Wang; Sohail Khan; Piers Blackett; Petar Alaupovic; Elisa Lee
Journal:  J Clin Lipidol       Date:  2012-07-02       Impact factor: 4.766

6.  Impact of type 1 diabetes and body weight status on cardiovascular risk factors in adolescent children.

Authors:  Sowmya Krishnan; Kenneth C Copeland; Brianna C Bright; Andrew W Gardner; Piers R Blackett; David A Fields
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-10       Impact factor: 3.738

7.  Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.

Authors:  Arpita Basu; Alicia J Jenkins; Julie A Stoner; Ying Zhang; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; David S Schade; Jamie Wood; Petar Alaupovic; Timothy J Lyons
Journal:  J Lipid Res       Date:  2018-03-25       Impact factor: 5.922

8.  Sex differences in HDL ApoC-III in American Indian youth.

Authors:  Piers R Blackett; Sohail Khan; Wenyu Wang; Petar Alaupovic; Elisa T Lee
Journal:  Biol Sex Differ       Date:  2012-08-16       Impact factor: 5.027

9.  Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes.

Authors:  Teresa Buckner; Baohai Shao; Robert H Eckel; Jay W Heinecke; Karin E Bornfeldt; Janet Snell-Bergeon
Journal:  J Clin Lipidol       Date:  2020-10-31       Impact factor: 5.365

10.  Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee.

Authors:  Wenyu Wang; Piers Blackett; Sohail Khan; Elisa Lee
Journal:  J Lipids       Date:  2017-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.